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Abstract
Surface plasmon resonance (SPR) biosensors have been recognized as a useful tool and widely used for real-time dynamic
analysis of molecular binding affinity because of its high sensitivity to the change of the refractive index of tested objects. The
conventionalmethodsin molecularbiology toevaluatecell differentiationrequire cell lysisorfixation, which make investigation
in live cells difficult. In addition, a certain amount of cells are needed in order to obtain adequate protein or messenger
ribonucleic acid for various assays. To overcome this limitation, we developed a unique SPR-based biosensing apparatus for
real-time detection of cell differentiation in live cells according to the differences of optical properties of the cell surface caused
by specific antigen-antibody binding. In this study, we reported the application of this SPR-based system to evaluate the
osteogenic differentiation of mesenchymal stem cells (MSCs). OB-cadherin expression, which is up-regulated during osteogenic
differentiation, was targeted under our SPR system by conjugating antibodies against OB-cadherin on the surface of the object.
A linear relationship between the duration of osteogenic induction and the difference in refractive angle shift with very high
correlation coefficient was observed. To sum up, the SPR system and the protocol reported in this study can rapidly and
accurately define osteogenic maturation of MSCs in a live cell and label-free manner with no need of cell breakage. This SPR
biosensor will facilitate future advances in a vast array of fields in biomedical research and medical diagnosis.
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Introduction
Dramatic progress in the biological understanding and the
potential clinical use of mesenchymal stem cells (MSCs) has been
made in recent years. MSCs have been initially identified in bone
marrow stroma as non-hematopoietic stem cells which are capable
of differentiation into tissues of mesodermal origin, such as
osteoblasts, adipocytes, chondrocytes, tenocytes, and hepatocytes
[1,2,3,4,5,6]. Due to their multi-lineage differentiation potentials,
many pre-clinical studies with tissue engineering approaches are
currently under investigation [7,8,9]. Previously, we have
established a platform to isolate and to expand single cell-derived,
clonally expanded MSCs from human bone marrow and umbilical
cord blood through negative immune-selection and limiting
dilution [6,10]. These single cell-derived hMSCs are highly
homogenous in morphology; and possess a high capacity of in
vitro expansion and multi-lineage differentiation.
Osteoblasts, which are progenies of MSCs, are bone-forming
cells and play an important role in the homeostasis of the skeletal
system [11,12,13]. Current strategies for the differentiation of stem
cells commonly include induction with mechanical or chemical
stimuli. To evaluate the maturation of osteogenic differentiation of
hMSCs during these processes, histochemical and molecular
biological methods such as alkaline phosphatase (ALK-p) staining,
von Kossa staining, Western blot, and reverse transcription
polymerase chain reaction (RT-PCR), are commonly used
[14,15,16]. However, all these traditional methods are time-
consuming with tedious process and can only provide semi-
quantitative or non-quantitative data except for the real-time RT-
PCR. Moreover, the conventional methods to detect the extent of
osteogenic differentiation require cell lyses or fixation, which
causes cell death and makes continuous analysis on the same cell
impossible.
Surface plasmon resonance (SPR) biosensors dedicated to
biomolecular dynamics and recently to cell analysis have
generated tremendous interest in developing new tools for both
diagnostic and research purposes. This technique is a surface-
sensitive method of increasing interest for bio-analysis as it allows
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functionalized surfaces [17,18,19,20,21,22]. The primary goals for
the development of this technique is to establish a method with
rapid live cell analysis, high throughput, and small sample volumes
[23]. For this purpose, selection of a proper surface marker for
osteogenesis is imperative. The cell transmembrane protein, OB-
cadherin, firstly cloned in 1994 [24,25], is known to selectively
express in osteoblastic cell lines, precursor cell lines of osteoblast,
and primary osteoblastic cells [26]. The purpose of this study is to
investigate whether the SPR technique can be used as a live cell
sensor to accurately define the different stages of osteogenic
maturation in live cells by detecting the expression of OB-cadherin
on cell surfaces.
Methods
2.1 Culture maintenance and expansion
For studies involving human tissues we obtained Institutional
Review Board approval of Taipei Veterans General Hospital on
March 24th, 2010 and written patient informed consent. Bone
marrow was collected from healthy young donors during fracture
surgery after Institutional Review Board approval and informed
consent. Mononuclear cells from the bone marrow were isolated
and MSCs were purified with negative immuno-selection and
limiting dilution as previously described [10]. SaOS2 [27] is an
OB-cadherin expressing cell line and is used as a positive control.
Hep3B is a human hepatoma cell line [28] and served as an OB-
cadherin non-expression control. Expansion medium for MSCs
consists of a commercially available medium (MesenPro, Gibco,
Grand Island, NY) supplemented with 100 U penicillin, 1000 U
streptomycin, and 2 mM L-glutamine (Gibco). Expansion medium
for SaOS2 and Hep3B consists of Iscove’s modified Dulbecco
medium (IMDM; Gibco, Grand Island, NY) and 10% fetal bovine
serum (FBS; Hyclone, Logan, UT) supplemented with 100 U
penicillin, 1000 U streptomycin, and 2 mM L-glutamine (Gibco).
2.2 Osteogenic differentiation
To induce osteogenic differentiation, MSCs were treated with
osteogenic medium for 15 days with medium changes every 3 to 4
days. Osteogenesis was analyzed every 3 days. Osteogenic medium
consists of IMDM supplemented with 0.1 mM dexamethasone
(Sigma-Aldrich, St Louis, MO), 10 mM b-glycerol phosphate
(Sigma-Aldrich), and 0.2 mM ascorbic acid (AsA; Sigma-Aldrich).
2.3 Cytochemical staining of osteogenic differentiation
To analyze osteogenesis, cells were rinsed twice with PBS, fixed
with 3.7% formaldehyde for 20 minutes, and washed with distilled
water. Alkaline phosphatase (Alk-P) histochemical stain was
performed using the nitroblue/BCIP solution (Roche Molecular
Biochemicals, location?) based on the manufacturer’s instructions.
Mineralization matrix was analyzed with von Kossa staining using
1% silver nitrate (Sigma-Aldrich) under UV light for 45 minutes,
followed by 3% sodium thiosulfate (Sigma-Aldrich) for 5 minutes,
and then counterstained with van Gieson (Sigma-Aldrich) for
5 minutes.
2.4 Antibody coating of Au chip
Au chip was immersed in 1 mM 11-MUA in 75% alcohol for
12 hr, followed by immersion in 2 mM:5 mM EDC/NHS for one
hour. The chip was then coated with 0.005 ug/ml protein G in
PBS for one hour, and bound with 0.05 ug/ml mouse IgG anti-
human OB cadherin (Abnova) or mouse IgG (sigma) in PBS for
one hour, and finally blocked in 1 mM BSA.
2.5 Surface plasmon resonance system
The experimental setups for the evaluation of osteogenic
differentiation of MSCs are schematically illustrated in Fig. 1.
The setup combines the platforms of the biosensor for the
excitation of surface plasmon polaritons (Fig. 1A) and a fluidic
cell chamber (Fig. 1B). As illustrated in Fig. 1A, a Helium–Neon
laser of wavelength 632.8 nm was used as the light source to
excite surface plasmon polaritons. The extinction ratio of beam
polarization was enhanced to 1000:1 through the aid of a
polarizer in front of the laser. This polarizer was oriented to let
only the p-wave pass. A beam splitter (BS) was used to separate
the laser beam into two beams. One p-wave was reflected to a
detector for normalization of the laser power instability and the
other was transmitted to excite surface plasmon polaritons. Since
the dispersion characteristic of surface plasmon polaritons forbids
a p-wave in free space couple to a surface plasmon wave due to
the smaller spatial phase of the wave in free space. A prism made
of SF11 adds an extra spatial phase on the laser beam through its
high refractive index, n=1.78, to match the dispersion relation of
the surface plasmon polaritons. For a practical reason, an Au thin
layer with thickness 47.5 nm was coated on a glass slide made of
SF11 as the platform of the surface plasmon polaritons. Matching
oil was applied between the prism and the glass slide to avoid
multi-reflection occurring between them. The energy coupling
between the laser beam in a free space and the surface plasmon
polaritons bound on the Au-dielectric interface was measured
through the reflection of the laser beam from the Au chip. This
reflection served as the indicator of the coupling or excitation
efficiency. This excitation efficiency was optimized when the
incident angle of the laser beam is properly adjusted. This
optimized incident angle, known as the resonance angle, is
determined by the refractive index of any material contacting the
Au chip and the wavelength of the excitation light beam as well.
In this system, the incident angle of the laser beam was controlled
by a motorized rotation stage through a controller, and a silicon
photodetector was controlled accordingly by another motorized
rotation stage to measure the power of the reflected laser beam.
These two rotation stages (Sigma Koki, SGSP-120YAW)
controlled by the two-axis controller (Sigma Koki, SHOT-202)
have the angular resolution of 2.5610
23 degrees. The intensity of
the reflected beam as a function of the incident angle was
recorded by a computer via 16-bit A/D converter (Adventech
PCI-1716). A cell chamber equipped with a fluidic channel was
constructed on the SPR platform to provide the living cells for
testing and to flow deionized (DI) water for stabilizing and for
washing unbound cells. The temperature of the cell chamber was
stabilized at 37uC by a TE cooler placed on the top of the
chamber. The temperature fluctuation is less than 0.1uC through
a temperature controller.
2.6 Experimental procedures
As depicted in Fig. 1B and Fig. 1C, undifferentiated MSCs,
MSCs under osteogenic induction for different days, Hep3B and
SaOS2 cells were individually mixed with PBS and injected into
cell chambers with Au chips and subject to three different surface
treatments: one without antibody coating, one with mouse IgG
antibody coating (non-specific binding control), and one with pre-
coated with OB-cadherin antibody. The flow rate and cell
number was controlled at 1000 cells/min. The angle shifts of
captured cells on Au chips subject to the three different surface
treatments were measured and recorded by the SPR system
operating in the angular interrogation mode as previously
described. After the angle increased to the level of saturation,
flushing with PBS was performed to wash out the cells until the
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population of cells was then injected on the Au chip for further
measurements.
2.7 Quantitative real-time PCR analysis
Total RNA was isolated from 3610
5 cells using Trizol
(Invitrogen) or a commercially available kit (RNA easy minikit,
Qiagen, Courtaboeuf, France). We reverse transcribed the
messengerRNAtocomplementaryDNAusingreagents(Genemark
Technology, Taiwan) according to the manufacturer’s instructions.
Quantitative real-time PCR analysis was performed and cDNA was
amplified at 95uC for 60 seconds, 56uC for 45 seconds, and 72uC
for 60 seconds for 40 cycles, after initial denaturation at 95uC for
5 minutes using an ABI Step One Plus Real Time PCR System.
The specific primer sequences are 59-AAACAGCCTGGCTCAA-
CATC-39 (forward) and 59-CTTCCTGATGCCGATTGTG-39
(reverse) for OB-cadherin; 59-AGCCACATCGCTCAGACAC-39
(forward) and 59-GCCCAATACGACCAAATCC-39 (reverse) for
GAPDH.
2. 8 Western blot analysis
10
6 cells were collected and resuspended in 200 ml Extraction
Buffer I and 1 ml protease inhibitors cocktail (Subcellular
proteome extraction kit, Merck). Cell lysate was incubated on
ice for 10 min. with gentle agitation and then centrifuged at
1000 g at 4uC for 10 min. The supernatant was collected, and
remixed in 200 ml Extraction Buffer II and 1 ml protease inhibitors
cocktail (Subcellular proteome extraction kit, Merck KGaA). Cell
lysate was incubated on ice for 30 min. with gentle agitation and
then centrifuged at 6000 g at 4uC for 10 min. The supernatant
was collected and protein concentration was measured by
Bradford assay (Bio-Rad, Hercules, CA). 10 mg/well of protein
was separated on 10% sodium dodecyl sulfate/polyacrylamide gel
electrophoresis and blotted onto a polyvinylidene difluoride
membrane (GE Healthcare Bio-Sciences, Piscataway, NJ). Non-
specific bindings were blocked by 5% skim milk in TBST buffer
(50 mmol/L Tris-HCl, 150 mmol/L NaCl, 0.1% Tween 20,
pH 7.4). The membrane was sequentially hybridized with the
primary anti-OB cadherin antibody (1:2000, Abcam) and with
Figure 1. SPR setups and experimental procedures. (A) Schematic illustration of the SPR device: The He-Ne laser penetrated through a
polarizer and a beam splitter, which split the beam 50/50. One was detected by a photodiode and the other one was coupled by a prism to generate
Surface Plasmon Wave on the Au chip in which the angle shift was detected by a photodiode. (B) The OB-cadherin expressing cells flowing into the
chamber were captured by the Au chip pre-coated with OB-cadherin antibodies, which changed the angle of the reflected laser beam. (C) A typical
graphical data from SPR measurements.
doi:10.1371/journal.pone.0022382.g001
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GE Healthcare Bio-Sciences) at room temperature for 1 hour.
Washes were performed between incubations. Protein intensity
was resolved with enhanced chemiluminescence reagent (Perki-
nElmer, Wellesley, MA).
Results
The mRNA and protein expression level of OB-cadherin
increased following the maturation of MSCs during osteoblast
differentiation (Fig. 2A and Fig. 2B). The OB-cadherin protein
expression level was measured by a semi-quantitative assay in
which the relative amount of immunoreactive bands on Western
blot film was quantified as arbitrary units using a computerized
software program (LabWorks 4.6; UVP Inc., Cambridge, UK) and
was normalized to the intensity of SaOS2 (Fig. 2C). The result
demonstrated an increase in OB-cadherin expression level as the
induction period increased. In addition, successful induction of
osteogenic differentiation was confirmed by alkaline phosphatase
(AP) and von Kossa staining (Fig. 2D). Since the expression of the
membrane molecule OB-cadherin is up-regulated during matura-
tion of osteoblasts, we therefore used it as a marker to analyze the
extent of differentiation by quantifying it under SPR system. In
order to eliminate non-specific binding of cells to Au chip and false
positives, SaOS2 and Hep3B cell lines were used as positive and
negative controls for the expression of Ob-cadherin respectively.
Furthermore, the Au chip without antibody pre-coating or with
mouse IgG antibody pre-coating were used as control groups to
eliminate non-specific binding of cells onto Au chip and IgG
antibodies. DI water was first injected into the cell chamber for
stabilization, followed by PBS as a baseline control. After the
injection of PBS, cells were injected for measurements. The true
angle shift of each cell line was evaluated by subtracting the
resonance angle in the corresponding test baseline from the SPR
resonance angle of bound and unbound cells. For the non-coating
control groups, SaOS2, Hep3B, and MSCs were injected into the
cell chamber without antibody pre-coated on the Au surface. As
expected, all the tested cell lines showed no significant difference
on bare Au chips because there is no antibody layer to perform
specific binding (Fig. 3A). For the antibody coating control groups,
the anti-OB cadherin and mouse IgG antibodies were first
immobilized on the sensor chips and bathed in a concentration
of 10
3 cells/ml PBS by the self-assembly monolayer (SAM) coating
method. The amount of resonance angle shift after injecting the
SaOS2, Hep3B, MSCs to the cell chamber with mouse IgG also
showed no significant difference because there is no specific cell-
Figure 2. Molecular biology detection of MSC-osteoblast differentiation. (A) Real-time PCR of OB-cadherin expression. (B) Western blot of
OB-cadherin expression during osteogenic induction of MSCs. SaOS2 served as positive control. (C) The OB-cadherin expression level intensity
analyzed by semi-quantitative method and was normalized to the intensity of SaOS2. (D) Alkaline phosphatase (AP) staining and von kossa (VK)
staining.
doi:10.1371/journal.pone.0022382.g002
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as the non-specific binding background of each cell line and were
denoted as Dhnon-MSC,Dhnon-Hep3B, and Dhnon-SaOS2 respectively
for later analysis. On the contrary, in the group with OB-cadherin
antibody coating, the angle shift of SaOS2 cells were distinguished
from the Hep3B and the MSCs at day zero. This result
demonstrated that SaOS2 has significantly higher OB-cadherin
expression on cell surfaces, but none on Hep3B and on MSCs
without osteogenic induction.
Since MSCs that express more OB-cadherin on the cell surface
had a better opportunity to be captured by the coated antibodies;
this results in an increment of refractive index in the detection
region, indicated by the angle shift. Therefore, the resonance angle
hMSC with a larger value would be obtained. The measurement
was first conducted by the injection of the MSCs into the cell
chamber. After the binding of MSCs reached the saturation status,
PBS was used to wash out the MSCs followed by the injection of
SaOS2 cells to measure the number of the active binding sites
expressed in the SPR angle shift. A typical curve of SPR angle shift
over the entire experimental procedure was demonstrated in
Fig. 1C. In order to investigate the relative expression of OB-
cadherin compared to the OB-cadherin positive SaOS2 cells, we
used the angle shift obtained from SPR measurements to calculate
the angle difference between the cells. As expression levels become
similar, the angle difference will approach zero. Using the
resonance angle before the injection of the MSCs as a reference
value, denoted by hM-PBS, to subtract the value of the non-specific
binding, Dhnon-MSC, the amount of OB-cadherin expression on the
membranes of the MSCs is then proportional to the shift of the
resonance angles as DhMSC:hMSC{hMPBS{Dhnon-MSC. During
each test, the different Au chip may have different number of
active binding sites formed by anti-OB-cadherin, this number of
active binding sites on the Au chip was measured by the angle shift
starting from the injection of SaOS2 and ending at the saturation
of the cell binding. The calculation can be formulated as
DhSaOS2:hSaOS2{hSPBS{Dhnon-SaOS2. In the experiment, the
relative value of the SPR angle shifts between MSCs and SaOS2
cells, indicated as OB-cadherin expression level Dh:DhSaOS2{
DhMSC, was normalized for data analysis. This normalization
eliminated the variation of anti-OB-cadherin coating for each
measurement. When the duration of osteogenic induction
increased, the experimental value of angle difference (D h h t ðÞ ) from
Figure 3. Resonance characteristics of antibody–antigen reaction on Au coated chips. (A) Test control of antibody non-coating system
and injected with SaOS2, Hep3B and MSCs onto Au chip. (B) Test control of antibody coating system by injecting SaOS2, Hep3B and MSCs onto
mouse IgG pre-coated Au chip. (C) The verification and stability test of OB-cadherin antibody-antigen binding by injecting SaOS2, Hep3B and MSCs.
doi:10.1371/journal.pone.0022382.g003
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proached to zero after 15-days (Fig. 4A).The interval of the MSC
culture time for this measurement is three days until OB-cadherin
levels on MSCs approached to the highest expression level and
bound to anti-OB-cadherin antibodies with the same binding
strength as SaOS2. This result suggested that both cell types are
similar in surface OB-cadherin expression on the 15th day.
Furthermore, when the angle difference Dh was normalized to
DhSaOS2 and denoted as D h h, this normalization eliminated the
variation of anti-OB-cadherin coating for each measurement. This
quantity D h h represents the complement of OB-cadherin expres-
sion. Therefore, the amount of OB-cadherin can be expressed as
 x x:1{D h h. The experimental value of OB-cadherin expression
level  x x from MSCs subject to different culture durations was
calculated. As expected, this angle difference approached to one
after 15 days when the duration of osteogenic induction increased
(Fig. 4B). The analysis showed that the expression level of OB-
cadherin increased linearly with the increase of the culture time
(days). By using this expression level curve as a standard, we could
easily predict the maturation level of unknown differentiated live
cells.
Discussion
In this study, we developed a real-time, cell-preserving, and
quantitative measurement method based on the surface plasmon
resonance bio-sensing technique to characterize the maturation of
osteoblasts by selective binding of a cell surface molecule, OB-
cadherin,whichisspecificallyandhighlyexpressedindifferentiating
osteoblasts. With pre-coated antibodies on an Au chip, alteration of
SPR angle shift could be accurately measured and analyzed. From
the data analysis, itwas found that the OB-cadherin expressionlevel
was increased as the culture time increased. The expression level
obtained in the SPR biosensing method correlated with the result
obtained by the conventional method of Western blot, but with
much higher sensitivity at nanogram levels [29]. This new
development offers a live cell tool to accurately define the different
stages of osteogenic differentiation in live cells. Moreover, although
the measurement was performed on osteoblast maturation, similar
approaches can be applied in future studies to quantify the
expression of OB-cadherin in tumor cells to predict their
invasiveness and to also use other surface markers to monitor
differentiation in other stem cell types [30].
In comparison with the results shown in Fig. 2C and Fig. 4B,
the OB-cadherin expression level obtained by the Western blot
assay in the early culture period did not match that obtained by
the SPR biosensor, especially before the 9
th day of osteogenic
differentiation. As shown in Fig. 2B, OB-cadherin expression was
undetectable before day 6, with relatively weak signals until day
12. It is evident that Western blot detection lacks the ability to
account for the vast range difference in OB-cadherin expression.
For example, OB-cadherin expression at day 6 can be enhanced
by prolonged exposure to chemiluminescent reagents. However,
this would also saturate the reaction of HRP and chemilumines-
cent reagents of the day 15 group, resulting in inaccurate
quantification. This explains why the relative quantitative level
of OB-cadherin obtained by Western blot did not coincide with
the result obtained by the SPR technique, but only coincided
qualitatively in trend of expression. In addition, the most valuable
advantage of this technique is its detection sensitivity whereby
differences in OB-cadherin expression could be quantitatively
distinguished by SPR technique during early differentiation stages
between day 0 and day 6 (Fig. 4A), and not by Western blot
(Fig. 2C). This also suggests that SPR is more accurate than the
conventional Western blot method. Most importantly, live cells
can be analyzed, which is not possible for the conventional
Western blot method.
In summary, this SPR protocol makes possible the quantitative
evaluation of different cell surface molecules on live cells in a time-
saving and cell-saving manner for future cell biology research.
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Figure 4. Angle shift difference during osteogenic differentiation of MSCs. (A) The angle difference, D h h, as a function of culture time. (B)
OB-cadherin expression normalized to SaOS2 during differentiation.
doi:10.1371/journal.pone.0022382.g004
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